Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.42 |
| ▸ | NPC1 | O15118 | 5/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | HK1 | P19367 | 1/20 | 0.40 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.39 |
| ▸ | BIRC5 | O15392 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5805651 | 0.83 | RAB9A (0.50) | RAB9ANPC1TSHRSMN1; SMN2TP53 | |
| SCHEMBL29398181 | 0.83 | RAB9A (0.50) | RAB9ANPC1TSHRSMN1; SMN2TP53 | |
| SCHEMBL16173656 | 0.81 | RAB9A (0.48) | RAB9ANPC1TSHRSMN1; SMN2TP53 | |
| SCHEMBL2278862 | 0.79 | ALDH1A1 (0.52) | RAB9ANPC1TSHRSMN1; SMN2TP53 | |
| SCHEMBL8588225 | 0.77 | ALDH1A1 (0.48) | RAB9ANPC1TSHRSMN1; SMN2TP53 | |
| SCHEMBL29671005 | 0.77 | ALDH1A1 (0.62) | RAB9ANPC1TSHRSMN1; SMN2TP53 | |
| SCHEMBL16383438 | 0.77 | ALDH1A1 (0.62) | RAB9ANPC1TSHRSMN1; SMN2TP53 | |
| SCHEMBL4142770 | 0.77 | ALDH1A1 (0.50) | RAB9ANPC1TSHRSMN1; SMN2TP53 | |
| SCHEMBL4121500 | 0.76 | TAAR1 (0.42) | SMN1; SMN2TP53MAOBMAPTHPGD | |
| SCHEMBL3282075 | 0.76 | TDO2 (0.42) | RAB9ANPC1TSHRSMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9469604-B2 | Method of manufacturing sulfonium salt | TOYO GOSEI CO., LTD. (JP) | 2016-10-18 | — | — | US | claimed |
| US-9469604-B2 | Method of manufacturing sulfonium salt | TOYO GOSEI CO., LTD. (JP) | 2016-10-18 | — | — | US | disclosed |
| US-20160068477-A1 | METHOD OF MANUFACTURING SULTONIUM SALT | TOYO GOSEI CO., LTD. (JP) | 2016-03-10 | — | — | US | disclosed |
| EP-2236488-A1 | Materials, methods and uses for photochemical generation of acids and/or radical species | The Arizona Board of Regents on behalf of the University of Arizona (US) | 2010-10-06 | — | — | EP | disclosed |
| US-7709548-B2 | Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product | SAN-APRO LIMITED (JP) | 2010-05-04 | — | — | US | disclosed |
| US-20090163723-A1 | METHOD FOR PRODUCING SULFONIUM FLUORINATED ALKYLFLUOROPHOSPHATE | SAN-APRO LIMITED (JP) | 2009-06-25 | — | — | US | disclosed |
| US-7459106-B2 | Materials, methods, and uses for photochemical generation of acids and/or radical species | THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2008-12-02 | — | — | US | disclosed |
| US-20080249270-A1 | Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product | DATE MASASHI | 2008-10-09 | — | — | US | disclosed |
| EP-1953139-A1 | METHOD FOR PRODUCING FLUORINATED SULFONIUM ALKYLFLUOROPHOSPHATE | San-Apro Ltd. (JP) | 2008-08-06 | — | — | EP | disclosed |
| EP-1350789-B1 | PROCESS FOR PRODUCING SULFONIUM SALT | SAN APRO LTD (JP) | 2008-06-25 | — | — | EP | disclosed |
| EP-1390664-A4 | MATERIALS, METHODS, AND USES FOR PHOTOCHEMICAL GENERATION OF ACIDS AND/OR RADICAL SPECIES | UNIV ARIZONA (US) | 2008-01-02 | — | — | EP | disclosed |
| US-20060247401-A1 | Process for production of monosulfonium salts, cationic polymerization initiators, curable compositions, and products of curing | SAN-APRO LIMITED (JP) | 2006-11-02 | — | — | US | disclosed |
| US-7060858-B2 | Method for manufacturing sulfonium salts | SAN-APRO LIMITED (JP) | 2006-06-13 | — | — | US | disclosed |
| EP-1640363-A1 | PROCESS FOR PRODUCTION OF MONOSULFONIUM SALTS, CATIONIC POLYMERIZATION INITIATORS, CURABLE COMPOSITIONS, AND PRODUCTS OF CURING | San-Apro Limited (JP) | 2006-03-29 | — | — | EP | disclosed |
| CN-1684944-A | method for copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INST TECHNOLOGY (US) | 2005-10-19 | — | — | CN | disclosed |
| US-20050173683-A1 | Materials, methods, and uses for photochemical generation of acids and/or radical species | THE ARIZ BD OF REGENTS ON BEHALF OF THE UNIV OF AZ (US) | 2005-08-11 | — | — | US | disclosed |
| EP-1390664-A1 | MATERIALS, METHODS, AND USES FOR PHOTOCHEMICAL GENERATION OF ACIDS AND/OR RADICAL SPECIES | The Arizona Board of Regents (US) | 2004-02-25 | — | — | EP | disclosed |
| US-20040030158-A1 | Method for manufacturing sulfonium salts | SAN-APRO LIMITED (JP) | 2004-02-12 | — | — | US | disclosed |
| EP-1350789-A1 | PROCESS FOR PRODUCING SULFONIUM SALT | San-Apro Limited (JP) | 2003-10-08 | — | — | EP | disclosed |
| WO-2002079691-A1 | MATERIALS, METHODS, AND USES FOR PHOTOCHEMICAL GENERATION OF ACIDS AND/OR RADICAL SPECIES | THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2002-10-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060247401-A1 | Process for production of monosulfonium salts, cationic polymerization initiators, curable compositions, and products of curing | RPS6, SPIN4, SRM | RAB9A 4357/4885NPC1 4800/4885TSHR 3341/4885 |
| US-20040030158-A1 | Method for manufacturing sulfonium salts | MLX, STS, SULT1A1 | RAB9A 3146/4885NPC1 2763/4885TSHR 3172/4885 |
| US-20090163723-A1 | METHOD FOR PRODUCING SULFONIUM FLUORINATED ALKYLFLUOROPHOSPHATE | ARSA, SCO2, DOHH | RAB9A 1097/4885NPC1 701/4885TSHR 158/4885 |
| US-20080249270-A1 | Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product | SPIN4, RPS6, SRM | RAB9A 4201/4885NPC1 4750/4885TSHR 3545/4885 |
| US-20160068477-A1 | METHOD OF MANUFACTURING SULTONIUM SALT | STS, SULT1A1, ARSA | RAB9A 1736/4885NPC1 3716/4885TSHR 1574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.